/KASE, December 28, 2017/ – Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has notified KASE of a KZT117,022,692.40 loan received on December 27, 2017 (in Kazakh and Russian) – see more

[2017-12-28]